Abrocitinib (Cibinqo, Abrocitinib Pfizer)
Abrocitinib
Pfizer Laboratories (Pty) Ltd
Registration
- Applicant
- Pfizer Laboratories (Pty) Ltd
- Registrations
- 6
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cibinqo 50 MG EACH TABLET CONTAINS ABROCITINIB 50,0 mg | 50 mg | 57022657/13.12/0226 | Registered | Not determined | None |
| Cibinqo 100 MG EACH TABLET CONTAINS ABROCITINIB 100,0 mg | 100 mg | 57022757/13.12/0227 | Registered | Not determined | None |
| Cibinqo 200 MG EACH TABLET CONTAINS ABROCITINIB 200,0 mg | 200 mg | 57022857/13.12/0228 | Registered | Not determined | None |
| Abrocitinib 50 MG pfizer EACH TABLET CONTAINS ABROCITINIB 50,0 mg | 50 mg | 570229.22657/13.12/0229.226 | Registered | Not determined | None |
| Abrocitinib 100 MG pfizer EACH TABLET CONTAINS ABROCITINIB 100,0 mg | 100 mg | 570230.22757/13.12/0230.227 | Registered | Not determined | None |
| Abrocitinib 200 MG pfizer EACH TABLET CONTAINS ABROCITINIB 200,0 mg | 200 mg | 570231.22857/13.12/0231.228 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
N-[3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide
Drag to rotate. Structure from PubChem CID 78323835.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.